Labcorp Holdings Inc.
LH- Exchange
- NYSE
- Industry
- Services-Medical Laboratories
- SEC CIK
- 0000920148
In the last 90 days, Labcorp Holdings Inc. insiders filed 0 open-market purchases and 6 sales; 1,061 institutions reported holding it in 13F filings for Q2 2026, worth $22.2B in total; Weitz Investment Management is the only superinvestor holding it.
Holders of 5% or more of LH
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Labcorp Holdings Inc., largest stake first. The change is against the holder's previous filing.
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| BlackRock, Inc. | 13G/A | 7.60%6.33M shares | – | Apr 24, 20251 filing | Apr 24, 2025 | SEC |
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
1 Schedule 13D or 13G filing on Labcorp Holdings Inc., newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Apr 24, 20259:37 AM ET | BlackRock, Inc. | 13G/A | 7.60%6.33M shares | – | Mar 31, 2025 | SEC |
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell Labcorp Holdings Inc. shares.
No Form 144 notices for Labcorp Holdings Inc. are on file.